Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Institutional Central Pathology and Molecular Risk-Based Stratification Study of Surgical Management for Melanoma, Atypical Spitz/Spitzoid Tumors, and Other Atypical Melanocytic Neoplasms in Pediatric Patients

NCT07621614 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT07621614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07621614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Institutional Central Pathology and Molecular Risk-Based Stratification Study of Surgical Management for Melanoma, Atypical Spitz/Spitzoid Tumors, and Other Atypical Melanocytic Neoplasms in Pediatric Patients
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Recruiting
Start date
May 15, 2027
Completion date
July 31, 2028
Enrollment
51 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

clinical stage 0 cutaneous melanoma ajcc v8, clinical stage i cutaneous melanoma ajcc v8, clinical stage ii cutaneous melanoma ajcc v8, cutaneous melanocytic neoplasm, cutaneous melanoma, cutaneous spitz melanocytoma, cutaneous spitz melanoma